Others Best Rated Abstract

P-10.1.1 - Hypertension Increases Graft Failure Rate After Autologous Chondrocyte Implantation

Authors
Corresponding Author
Award
Best Rated Abstract
Presentation Topic
Others
Poster Rating
 | 

Previous ePoster
P241 - Si-HPMC/Si-Chitosan hybrid hydrogel for cartilage regenerative medicine: from in vitro to in vivo assessments

Next ePosters
P-10.1.5 - Neuromuscular Control and Strength 1-year following Autologous Chondrocyte Implantation (ACI) and 5-Year Patient-Reported Outcomes
P-10.1.8 - Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation
P-10.1.9 - The short-term outcomes of autologous chondrocyte implantation associated with an atelocollagen-based scaffold
P-10.1.10 - Trochlear Dysplasia Does Not Affect the Outcomes of Patellofemoral Autologous Chondrocyte Implantation
P-10.2.3 - Prospective Evaluation of a Fresh Amniotic Membrane for the Treatment of Cartilage Defects
P-10.2.7 - Three dimensional knee kinematics and kinetics in ACL-deficient patients with and without MMPHT during level walking
P-10.2.8 - Magnetic Resonance Quantification of Meniscus Vascularity in Pediatric Versus Adult Knees
P-10.2.10 - Modelling and predicting the long-term clinical outcome of Autologous Chondrocyte Implantation
P-10.3.1 - Wnt Pathway Modulation via CLK2 and DYRK1A Inhibition by Lorecivivint, a Potential Disease-Modifying Treatment for Knee Osteoarthritis
P-10.3.2 - Lorecivivint (SM04690): An Intra-articular Wnt Pathway Inhibitor for Knee Osteoarthritis Treatment - Phase 2b Patient-Reported Outcomes